https://european-biotechnology.net/wp-content/uploads/2026/02/priyanka-singh-Jt72_opb38I-unsplash-1030x773-1.jpg7731030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-09 16:56:282026-02-09 16:56:28Dublin-based Aerska secures $39M Series A to push RNA medicines into the brain
https://european-biotechnology.net/wp-content/uploads/2026/02/alev-takil-7ojyp-IXW7w-unsplash.jpg480640Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-09 09:05:592026-02-09 09:05:59U.K. life sciences infrastructure gets a boost as London and Cambridge expand
https://european-biotechnology.net/wp-content/uploads/2026/02/pexels-guillaume-falco-1112556-2229887-1030x773-1.jpg7731030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-06 16:16:042026-02-06 16:16:04BioArctic is cashing in on Eisai and Biogen growing sales in Alzheimer’s disease
https://european-biotechnology.net/wp-content/uploads/2026/02/mackenzie-marco-XG88BYDSDZA-unsplash.jpg427640Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-06 10:48:552026-02-06 10:48:55Agomab goes public on Nasdaq as biotech IPOs top $1bn in a single week
https://european-biotechnology.net/wp-content/uploads/2025/10/NOVARTIS-HQ_508908319_Michael-Derrer-Fuchs-e1761645824248.jpg538958Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-06 09:14:112026-02-06 09:14:11Novartis celebrates strong profits, while the CEO enjoys record pay triggering discussion
https://european-biotechnology.net/wp-content/uploads/2026/02/diana-polekhina-REYb3IaZjj4-unsplash.jpg427640Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-05 14:59:092026-02-05 14:59:09Leyden Labs reports first human data for intranasal flu prevention antibody
https://european-biotechnology.net/wp-content/uploads/2025/11/eb-20251113-virometix-AdobeStock_435941317-1030x579-1.jpeg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-05 12:09:152026-02-05 17:32:02Pentixapharm: positive Phase II data on Pentixafor PET diagnostics pave way for radiotherapeutics
https://european-biotechnology.net/wp-content/uploads/2026/02/gabriella-clare-marino-MixRWeKSICI-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-05 09:32:112026-02-05 09:32:11PharosAI partners with 10x Genomics on spatial cancer data backed by £18.9 million
https://european-biotechnology.net/wp-content/uploads/2026/02/Photo-credits-Karolina-Grabowska-on-Pexels-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-04 14:46:512026-02-04 14:46:51Cereno widens clinical program as competition heats up in lung disease
https://european-biotechnology.net/wp-content/uploads/2026/02/pexels-traf-3105062.jpg427640Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-03 15:12:412026-02-03 15:12:41Poxel takes first step in recovery plan with €5 million equity line
